10.11.16
9:00 a.m. – 12:00 p.m. Nov 14, Exhibit Hall, Room 2
Speakers: Cornell Stamoran, Ph.D. Vice President, Strategy, Catalent, Inc.; Dr. Keith Horspool, Vice President of Pharmaceutical Development US, Boehringer-Ingelheim; Jeff Browne, Director, Science & Technology, Catalent Pharma Solutions; Elanor Pinto-Cocozza, Technical Specialist, Sales & Marketing Catalent Pharma Solutions; Julien Meissonnier, Vice President, Science and Technology, Catalent Pharma Solutions
A cross-disciplinary discussion of how early application of new formulation technologies and techniques drives a faster, more efficient, and reduced risk drug development process. Presenters include decision makers and top experts on multiple drug delivery technologies, drug design approaches, parallel feasibility, analytical and pre-formulation studies, data driven decisions, and more.
Speakers: Cornell Stamoran, Ph.D. Vice President, Strategy, Catalent, Inc.; Dr. Keith Horspool, Vice President of Pharmaceutical Development US, Boehringer-Ingelheim; Jeff Browne, Director, Science & Technology, Catalent Pharma Solutions; Elanor Pinto-Cocozza, Technical Specialist, Sales & Marketing Catalent Pharma Solutions; Julien Meissonnier, Vice President, Science and Technology, Catalent Pharma Solutions
A cross-disciplinary discussion of how early application of new formulation technologies and techniques drives a faster, more efficient, and reduced risk drug development process. Presenters include decision makers and top experts on multiple drug delivery technologies, drug design approaches, parallel feasibility, analytical and pre-formulation studies, data driven decisions, and more.